Clinical Trial Update: A Randomized, Single Centre, Double-blind, Parallel, Sham-controlled Pilot Study Using gammaCore®-G [NA]

View source ↗

Summary

A small randomized, single-centre, double-blind, sham-controlled pilot study evaluated the gammaCore-G device for dyspepsia and irritable bowel syndrome; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspepsia
• Irritable Bowel Syndrome

Drugs mentioned

• gammaCore-G

Snippet

Sponsor: ElectroCore INC | Conditions: Dyspepsia, Irritable Bowel Syndrome | NA | Status: COMPLETED | Results posted: 2018-02-06